Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling.
Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling.
复制标题
DOI:
10.1016/j.bbrc.2015.01.098
复制
发表时间:
2015-03
影响因子:
3.1
通讯作者:
Y. Yoshino;M. Ishisaka;Saori Tsujii;M. Shimazawa;H. Hara
中科院分区:
文献类型:
--
作者:
Y. Yoshino;M. Ishisaka;Saori Tsujii;M. Shimazawa;H. Hara
Alzheimer's disease (AD) is a common neurodegenerative disease characterized by cognitive dysfunction and neuronal cell death in the hippocampus and cerebral cortex. Glucagon-like peptide-1 (GLP-1) is an insulinotropic peptides. GLP-1-associated medicines are widely used as treatments for type 2 diabetes. In addition, they have been shown to ameliorate pathology in AD mouse models. Here, we investigated the effects of GLP-1 on different stressors in murine hippocampal HT22 cells. GLP-1 (7–36) prevented H2O2-,l-glutamate-, tunicamycin-, thapsigargin-, and amyloid β1–42-induced neuronal cell death in a concentration-dependent manner. GLP-1 (7–36) treatment for 1 h significantly increased phosphorylated Akt and extracellular signal-regulated kinase 1 and 2 (ERK1/2) when compared with vehicle-treatment. These results suggest that GLP-1 (7–36) is protective against these stressorsviaactivation of survival signaling molecules, such as Akt and ERK1/2 in HT22 cells. In conclusion, GLP-1 and activators of the GLP-1 receptor might be useful targets for the treatment of AD.